Category: impact giving
Philanthropic giving: Exploring the balance between cause and effect.
Assuming both are important where do you think priority should lie?
VIEW POSTMedical Research: Seeking the Right Company
Australia excels in biomedical research but sucks at commercialisation. Professor Frank Gannon says that needs to change. This article, written by Graeme O’Neill, previously appeared in Lab + Life Scientist. Professor Gannon is director of the QIMR Berghofer Medical Research Institute, formerly known as the Queensland Institute of Medical Research. The institute is dedicated to […]
VIEW POSTPhilanthropy: Benefiting from Constructive Failure
In our last post, we mentioned failure and how grant makers should not only have a way around measuring success for grants that worked to plan, but also for grants that haven’t. We thought this topic should be explored in a little more detail. Research by its nature has the ability to fail. Researchers take […]
VIEW POSTAdvancing biomedical innovations & enabling collaborations: “The long and the short of measuring success”
Measuring success when supporting biomedical research can be difficult. This is particularly relevant if there is no predetermined agreement of what success looks like or no strategy to guide how you contribute to the larger picture. Often governments, researchers and the community use terms such as ‘bench to bedside’ (beginning and end) when considering the […]
VIEW POSTIt’s good to give
Since 2001, wealthy Australian families have been increasingly taking advantage of Private Ancillary Funds (PAFs) as a vehicle to structure their giving. What these funds provide is no surprise; tax deductibility paired with the ability to custom-design your own support to the causes chosen by you and your appointed directors (which are often family members). […]
VIEW POSTWhy is Australia’s giving leveling-off?
Despite recent growth of high-net-worth individuals giving large sums publically, JBWere’s Giving Trends Report found that overall giving has stalled. Generosity Magazine interviewed the author, John McLeod, who reported that “Despite thirty years of steady growth in Australian philanthropy, overall giving appears to have plateaued following the Global Financial Crisis and that the latest report […]
VIEW POSTPhilanthropic tax incentives or opening Pandora’s box?
Should governments consider the introduction of an additional tax incentive to encourage philanthropy? Governments could choose to accredit certain organisations, select priority areas and or strategies for support and provide a new tax incentive to encourage donations. Tax incentives to support investment are not new. Australia’s R&D tax incentive program has successfully encouraged investment […]
VIEW POSTDo donors really care if a charity is effective?
Donors have many opportunities to give to various charities working across every possible sector. But what really captivates them? Is it the charity’s marketing campaign and branding, the cause it is aiming to address, connections to the executives running the show, celebrity endorsement or is it the strategy and the effectiveness of the organisation in […]
VIEW POSTLooking back through the microscope at medical research – Part 3
Previous posts: Part 1, Part 2 Part 3 of looking back through the microscope at medical research attempts to encourage conversation about making effective, strategic social investments in biomedical research. As with any business, donor or government, resources are not infinite and outcomes are best achieved by getting the balance right in what is supported […]
VIEW POSTLooking back through the microscope at medical research – Part 2
Part 1 of this blog started with a conversation looking at current funding models and the way they influence the priorities of researchers and their institutions. Part 2 continues to prompt the conversation by looking at the relationship between these measures, publications and the delivery of impact from biomedical research. The funding models […]
VIEW POST
